Revenue segments as reported by the company.

Electronics & Industrial

Water & Protection

Corporate & Other

Mobility & Materials

Corporate

Electronics & Imaging

Nutrition & Biosciences

Transportation & Industrial

Safety & Construction

Non-Core

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Research and development expenses

Selling, general and administrative expenses

Amortization of intangibles

Restructuring and asset related charges - net

Goodwill impairment charges

Acquisition, integration and separation costs

Equity in earnings of nonconsolidated affiliates

Sundry income (expense) - net

Interest expense

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

DuPont de Nemours

Danisco is a Danish bio-based company with activities in food production, enzymes and other bioproducts as well as a wide variety of pharmaceutical grade excipients. It was formed in 1989 from the largest Danish industrial merger ever of the two old C.F. Tietgen companies Danish Sugar (founded 1872), and Dansk Handels- og Industri Company (Danisco A/S).

Danisco

Solae was an international soy ingredients supplier based in St. Louis, Missouri. Solae was formed as a joint venture between DuPont and Bunge Limited. On May 1, 2012, Solae announced that DuPont had acquired Bunge's 28% share, thus taking full ownership of the company. DuPont then merged Solae's business into Danisco. The company developed food, feed and industrial ingredients, focusing on soy. Many of the studies supporting the Food and Drug Administration-approved health claim were based on research using Solae soy protein.

Solae

DuPont de Nemours, Inc. is a holding company, which engages in the development of specialty materials, chemicals, and agricultural products. It operates through the following segments: Electronics and Industrial, Water and Protection, and Corporate and Others. The Electronics and Industrial segment involves the supply of differentiated materials and systems for a broad range of consumer electronics including mobile devices, television monitors, personal computers and electronics used in a variety of industries. The Water and Protection segment focuses on the provision of engineered products and integrated systems for many industries including worker safety, water purification and separation, aerospace, energy, medical packaging and building materials. The company was founded in 1897 and is headquartered in Wilmington, DE.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

DuPont reports strong Q4 results, eyes growth amid challenges

DuPont's Q4 performance showcased organic revenue growth and margin improvement, supported by strategic actions and portfolio transformation.
While facing challenges in the shelter business and market conditions, DuPont remains focused on innovation, growth opportunities, and shareholder value enhancement.
The company's outlook for 2023 includes solid top-line growth, operational targets, and a strategic focus on managing challenges and leveraging growth opportunities.

DuPont exceeds Q1 expectations, eyes healthcare growth amid market challenges

DuPont's Q1 performance was solid, with revenue and adjusted EPS surpassing guidance, driven by acquisitions and ongoing market strengths. Challenges in the electronics market and inventory destocking impacted full-year guidance, but opportunities for growth in healthcare and other sectors are on the horizon. The company's focus on sustainability and operational efficiency remains key.

DuPont reports resilient Q2 performance amidst market challenges

DuPont's Q2 performance showed resilience amid market challenges, with a focus on strategic priorities for long-term growth.
While facing volume pressures and market uncertainties, DuPont is leveraging acquisitions and cost controls to drive value.
Opportunities lie in sequential business improvements, cost reductions, and sustainability-focused sales strategies.
Challenges include market-specific declines and regional growth variations that require strategic adjustments.

DuPont reports solid Q3 earnings amidst China challenges and growth opportunities

DuPont's Q3 performance showcased resilience amid challenges, with revenue declines offset by improved margins and EPS growth. Strategic acquisitions and divestitures are driving the company forward.
Despite facing headwinds in China and inventory destocking, DuPont is capitalizing on opportunities in semiconductors and other key segments. Efforts to enhance efficiency and target growth areas position the company for future success.
While challenges like trade restrictions and industrial destocking persist, DuPont remains focused on leveraging growth opportunities in AI, electronics, and other segments. Maintaining a strong cash position and returning value to shareholders are key priorities.

DuPont reports Q4 2023 results, eyes growth in key markets

DuPont's Q4 performance saw declines in net sales and EBITDA, but the company remains resilient amidst market challenges. Cost-saving initiatives and share repurchase programs demonstrate strategic financial management.
Despite absorption headwinds and challenges in China, DuPont's focus on key markets like semiconductors and water positions it for growth. The company's long-term EBITDA margin outlook is positive.
Opportunities in market stabilization, recovery in key sectors, and potential growth in water and electronics segments offer DuPont avenues for future expansion and profitability.

DuPont surpasses Q1 expectations, eyes growth amid market challenges

DuPont's Q1 2024 performance exceeded expectations, prompting an upward revision of full-year guidance across key financial metrics.
The company's focus on operational excellence, sustainability, and market diversification positions it well for recovery and growth in 2024 and beyond.
While facing challenges in pricing and market dynamics, DuPont's strategic initiatives and opportunities in key segments offer avenues for future growth.
Overall, DuPont's strong performance, prudent risk management, and focus on innovation and efficiency underscore its resilience and potential for sustained success.

DuPont surpasses Q2 expectations, eyes growth in tech and China

DuPont delivered strong Q2 2024 results, exceeding guidance and showcasing resilience across key segments.
Strategic initiatives like the Donatelle acquisition and planned separation activities position DuPont for future growth and market leadership.
While legal challenges persist, DuPont's proactive approach and focus on innovation and diversification bode well for long-term success.

DuPont reports strong Q3 earnings and progresses on strategic separations

DuPont's Q3 earnings call reflects a robust performance with growth in key financial metrics and segments. The company's focus on operational excellence and strategic initiatives has positioned it for continued success. While challenges exist, DuPont's ability to capitalize on opportunities and drive innovation bodes well for future growth and value creation.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

DuPont (DD) gains from higher pricing, portfolio actions and cost control amid a challenging macroeconomic environment in Q3.

DuPont (DD) Beats on Q3 Earnings & Sales, Narrows EPS View

DuPont's (DD) Q3 adjusted earnings of 96 cents per share surpassed the Zacks Consensus Estimate of 95 cents.

DuPont's (DD) Q3 Earnings and Sales Beat Estimates

DuPont DD, -2.60% largely reiterated guidance after it reported a 26% decline in third-quarter net income to $372 million, or 50 cents a share, as sales fell 5% to $5.4 billion and organic sales slipped 2%.

DuPont reiterates sales view as profit drops 26%

DuPont (NYSE: DD) Post restructuring DuPont‘s total expenses are expected to form a higher % of Total Revenue in 2019 and thus reducing Net Income margin to around 1.6% in 2019. DuPont has its expenses largely clubbed under its Cost of Sales expense.

How Are DuPont’s Expenses Expected To Change Post Restructuring?

DuPont technique helps investors to analyze basic ROE at an advanced level. Bet on these three stocks.

Believe in DuPont Analysis? Buy These 3 Top-Ranked Stocks

General Motors

Lloyds Banking Group

Prudential

Charles Schwab

Although gurus hold positions in the following companies, their share prices and returns have suffered recent declines.

6 Guru Stocks Underperforming The Market

Align Technology

Cigna

ETRADE

FedEx

Marathon Oil

Tapestry

If you still own these stocks, watch out for more losses ahead.

Tax-loss selling leaves these losing stocks with more room to fall, Morgan Stanley says

The buyout is in sync with DuPont's (DD) commitment to invest in specialty solutions aligned with attractive, high-growth end markets.

DuPont to Acquire Memcor Membrane Product Line From Evoqua

iRobot

NextDecade

Those chasing huge returns will likely have better luck with these top picks.

About to Buy Penny Stocks ? - Look at These 3 Companies First

BASF SE

The buyout will add to DuPont's (DD) portfolio of water purification and separation technologies, expanding its water purification capabilities.

DuPont (DD) to Buy BASF's Ultrafiltration Membrane Business

DuPont (NYSE:DD), whose stock is currently trading at around $72, generates its revenue primarily from its Nutrition and Biosciences segment, which is projected to account for 30.3% of total revenues in FY 2019, while the Transportation & Advance Polymers segment is expected to be the 2nd highest.

How Does DuPont Make Money?

DuPont's stock has underperformed the broader market since Corteva was spun off (the last of the Dow-DuPont spin-offs).

DuPont Is Well-Positioned For The Future

Bet on five top-ranked stocks with higher ROE derived the DuPont way.

5 DuPont-Tested Quality Stock Picks

The divestment is in sync with DuPont's (DD) strategy of active portfolio management.

DuPont to Sell Silicon Carbide Wafer Business to SK Siltron

Shares of DuPont de Nemours Inc (NYSE: DD) have higher resilience to a soft macro environment, given the company’s better operating discipline and “commitment to exploit its freedom to maneuver,” according to Jefferies.

Jefferies Begins DuPont With Bullish View, Says Optionality, Discipline Create Resilience

Have more faith in DuPont analysis than the simple ROE calculation and bet on these five stocks.

5 Top-Ranked Stocks Screened on DuPont Criteria

DuPont de Nemours (DD) stock may be a good choice for value-oriented investors right now from multiple angles.

Is DuPont de Nemours (DD) a Great Pick for Value Investors?

Corteva Inc

Dow Inc

The chemical industry heavyweight is gone, and DuPont and Dow are officially back -- but very different. Here's how to keep track of the new companies.

After the DowDuPont Split: An Investor’s Guide to the 3 New Companies

Industrial materials maker DuPont  is considering the sale of its nutrition and biosciences unit, CNBC said in a tweet on Tuesday, citing a report.

DuPont considers sale of nutrition and biosciences unit

Shares of DuPont de Nemours Inc. (NYSE:DD) closed 0.65% lower at $71.69 Thursday after the company issued second-quarter results.

DuPont de Nemours Tops Analysts on Earnings

DuPont de Nemours' (DD) CEO Marc Doyle on Q2 2019 Results - Earnings Call Transcript

DuPont (DD) gains from cost and pricing actions in Q2. The company raises adjusted earnings per share guidance for 2019.

DuPont's (DD) Earnings Top, Sales Trail Estimates in Q2

DuPont de Nemours (NYSE: DD) reported second-quarter earnings of 97 cents per share, which beat the analyst consensus estimate of 82 cents by 18.29%.

DuPont de Nemours Reports Mixed Q2 Earnings, Raises Guidance

Materials company DuPont de Nemours Inc. said Thursday it had a net loss of $571 million, or 76 cents a share, in the second quarter, after earnings of $1.769 billion, or $2.27 a share, in the year-earlier period.

DuPont tops profit estimates for second quarter but sales fall short

DuPont's (DD) Q2 adjusted earnings of 97 cents per share topped the Zacks Consensus Estimate of 86 cents.

News for DuPont de Nemours Stock (DD)